| TRADING CENTER |
| INTERVIEW-Human Genome calls hepatitis drug sleeper product - Reuters | |
| Caterpillar Tops the Dow ($) - at TheStreet.com | |
| What Bipartisan Health-Care Reform Means for Investors - MotleyFool.com | |
| Don't Invest Another Penny - MotleyFool.com | |
| Some Gray Amid the Black-and-White Thinking ($) - at TheStreet.com | |
| Bone Up On This Potential Blockbuster - MotleyFool.com | |
| The Best Undercover Dividends - MotleyFool.com | |
| Critical Alerts for Merck, Lowe's, MEMC Electronic Materials, Lennar, and Kinros... - PR Newswire | |
| EU Approves Merck's Elonva - Analyst Blog - Zacks.com | |
| You'll Become a Millionaire -- Here's When - MotleyFool.com | |
| Broker comments lift pharma stocks - FT.com | |
| GE Shares Continue Losing Streak - at TheStreet.com | |
| Compelling Companies With Competitive Advantages - MotleyFool.com | |
| Three Safe Stocks With Good Yield ($) - at TheStreet.com | |
| WRAPUP 3-Drugmakers Pfizer, Roche disappoint with forecasts - Reuters |
| Last trade | Change/%change | P/E ratio | ||
|---|---|---|---|---|
| JNJ | Johnson & Johnson | 62.76 | 0.39 / 0.63% | 13.56 |
| PFE | Pfizer Inc | 17.88 | 0.04 / 0.22% | 8.85 |
| NVS | Novartis AG | 53.58 | 0.50 / 0.94% | 14.52 |
| 2008 Revenue: | $23.9 B | Headquarters: Whitehouse Station, NJ |
| Employees: | 55,200 | CEO: Richard T. Clark |
| Net Income: | $7.8 B | Industry: Pharmaceuticals |
| Market Cap: | $113.4 B | Website: www.merck.com |
| Symbol | Price | Change/%Change | Prev. close | High | Low | Last Update | More Info |
|---|---|---|---|---|---|---|---|
| MRK | 36.47 | -0.12 / -0.33% | 36.59 | 37.17 | 36.32 | Profile Chart News |